Seeing Is Believing
Currently out of the existing stock ratings of Salveen Richter, 112 are a HOLD (32.84%), 202 are a BUY (59.24%), 27 are a SELL (7.92%).
Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 65.25% that have a potential upside of 34.34% achieved within 263 days.
Salveen Richter’s has documented 633 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 25-Sep-2025.
Analyst best performing recommendations are on ALLO (ALLOGENE THERAPEUTICS).
The best stock recommendation documented was for ALLO (ALLOGENE THERAPEUTICS) at 10/7/2021. The price target of $20 was fulfilled within 1 day with a profit of $4.38 (17.97%) receiving and performance score of 179.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$33
$11.2 (51.38%)
$34
9 days ago
(28-Sep-2025)
8/13 (61.54%)
$11.68 (54.78%)
113
Buy
$28
$6.2 (28.44%)
$30
14 days ago
(23-Sep-2025)
0/10 (0%)
$6.74 (31.70%)
Buy
$39
$17.2 (78.90%)
$35
27 days ago
(10-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
Buy
$39
$17.2 (78.90%)
$32
29 days ago
(08-Sep-2025)
1/5 (20%)
$14.16 (57.00%)
349
Hold
$24
$2.2 (10.09%)
$23
2 months 1 days ago
(06-Aug-2025)
10/13 (76.92%)
$-0.4 (-1.64%)
157
Which stock is Salveen Richter is most bullish on?
Which stock is Salveen Richter is most reserved on?
What Year was the first public recommendation made by Salveen Richter?